Detailed answers about KRISHNA MEDICAL ADVISORY CONSULTANCY LTD, including incorporation, status, business activity, and accounts information.
When was KRISHNA MEDICAL ADVISORY CONSULTANCY LTD founded?
KRISHNA MEDICAL ADVISORY CONSULTANCY LTD was officially incorporated on 30 April 2026 and is registered under company number 17192926. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is KRISHNA MEDICAL ADVISORY CONSULTANCY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of KRISHNA MEDICAL ADVISORY CONSULTANCY LTD?
KRISHNA MEDICAL ADVISORY CONSULTANCY LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does KRISHNA MEDICAL ADVISORY CONSULTANCY LTD do?
KRISHNA MEDICAL ADVISORY CONSULTANCY LTD operates in the following sectors: 70229 - Management consultancy activities other than financial management, 86220 - Specialists medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is KRISHNA MEDICAL ADVISORY CONSULTANCY LTD's registered address?
The registered office address of KRISHNA MEDICAL ADVISORY CONSULTANCY LTD is 71-75 Shelton Street, Covent Garden, London, United Kingdom, WC2H 9JQ. This is the official address filed with Companies House for legal and statutory correspondence.
Is KRISHNA MEDICAL ADVISORY CONSULTANCY LTD financially stable?
Financial accounts for KRISHNA MEDICAL ADVISORY CONSULTANCY LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.